search
IPOs
Trends
- 1Lambda Raising $4 Billion Ahead of Planned IPO●Exclusive | AI-Computing Startup Lambda Is Raising $4 Billion in Final Round Before Planned IPO
AI-computing startup Lambda is raising $4 billion in what is reported to be its final funding round before a planned initial public offering, according to the Wall Street Journal. The company, which provides GPU cloud services used for training and running artificial intelligence models, is one of several AI infrastructure firms attracting large investments as demand for computing power surges.
- 2GCash IPO opens door for retail investors●Want to buy GCash shares? How retail investors can join the IPO https:// fed.brid.gy/r/https://www.rapp ler.com/business
GCash, the Philippines' dominant mobile wallet operator, is heading to a public listing, and Rappler has published a guide explaining how ordinary retail investors can buy shares in the IPO. The piece walks through the steps individuals need to take to participate in the offering, highlighting growing interest among Filipino small investors in owning a stake in the country's biggest fintech company.
- 3
Lambda, an AI computing startup, is reportedly raising $4 billion ahead of a planned initial public offering. The company provides GPU cloud services used for training and running AI models, putting it among the infrastructure players benefiting from surging demand for artificial intelligence compute. The funding round and IPO plans signal continued investor appetite for AI-related companies.
- 4Medicare Counts Vested Startup Stock Even If Never Sold●His Employer Goes Public at a $35 Billion Valuation. Medicare Can Count the Stock When It Vests, Even If He Never Sells a Share
A worker's employer has gone public at a $35 billion valuation, raising an unexpected tax issue: Medicare's income-related premiums can count vested stock as income the moment it vests, even if he never sells a single share. Personal finance commentators are highlighting the case as a cautionary tale for employees holding newly public company shares, who may face steep Medicare surcharges on paper gains they never cashed in.